| Literature DB >> 31379461 |
Jose A Delgado Rodríguez1, Maria I Pastor García1, Cristina Gómez Cobo1, Antonia R Pons Más1, Isabel Llompart Alabern1, Josep Miquel Bauça1,2.
Abstract
INTRODUCTION: Communication of laboratory critical risk results is essential for patient safety, as it allows early decision making. Our aims were: 1) to retrospectively evaluate the current protocol for telephone notification of critical risk results in terms of rates, efficiency and recipient satisfaction, 2) to assess their use in clinical decision making and 3) to suggest alternative tools for a better assessment of notification protocols.Entities:
Keywords: clinical decision making; critical risk result; phone notification; turnaround time
Mesh:
Substances:
Year: 2019 PMID: 31379461 PMCID: PMC6610674 DOI: 10.11613/BM.2019.030703
Source DB: PubMed Journal: Biochem Med (Zagreb) ISSN: 1330-0962 Impact factor: 2.313
Critical results requiring phone notification
| Calcium (mmol/L) | < 1.6 or > 3.2 |
| Chloride (mmol/L) | < 75 or > 120 |
| Ethanol (mmol/L) | > 0.9 |
| Glucose (mmol/L) | < 2.2 or > 25 |
| Magnesium (mmol/L) | < 0.6 or > 2.1 (adults); |
| Phosphate (mmol/L) | < 0.3 or > 2.9 |
| Potassium (mmol/L) | < 2.5 or > 6.5 |
| Sodium (mmol/L) | < 125 or > 160 |
| Troponin I (ng/L)* | > 80 (women); > 170 (men) |
| Ionized calcium (mmol/L) | < 0.8 or > 1.6 |
| pH | ≤ 7.20 or ≥ 7.60 |
| pCO2 (kPa) | < 2.7 or > 9.3 (arterial) |
| pO2 (kPa) | < 6.0 (arterial) |
| Bicarbonate (mmol/L) | < 10 or > 40 (arterial) |
| Acetaminophen (µmol/L) | > 123 |
| Carbamazepine (µmol/L) | > 85 |
| Cyclosporine (nmol/L) | > 500 |
| Digoxin (nmol/L) | > 2.8 |
| Lithium (mmol/L) | > 2.0 |
| Phenytoin (µmol/L) | > 79 |
| Phenobarbital (µmol/L) | > 172 |
| Salicylate (mmol/L) | > 2.9 |
| Theophylline (µmol/L) | > 222 |
| Valproate (µmol/L) | > 693 |
| *Only emergency room is notified. **The established critical values were based on agreement between physicians and laboratory professionals. | |
Results and classification of the notifications
| Primary care | 2.807,822 | 170 | 156 (92) | 0 | 19 | Acceptable | |
| Hospitalized | 936,167 | 1407 (0.15) | 583 (41) | 0 | 15 | Acceptable | |
| Outpatients | 750,293 | 136 (0.02) | 96 (71) | 1 (0.7) | 21 | Acceptable | |
| Other | 264,333 | 92 (0.03) | 71 (77) | 0 | 18 | Acceptable | |
| Total | 4.758,615 | 1805 (0.04) | 906 (50) | 1 (0.1) | 17 | Acceptable | |
| Emergency Room | 646,706 | 3796 (0.59) | 3212 (85) | 13 (0.3) | 3 | Timely | |
| 5.405,321 | 5601 (0.10) | 4118 (74) | 14 (0.3) | 4 | Timely | ||
| *The percentage of critical results was calculated with respect to the total number of results in that area. **The percentage of notified critical results was calculated with respect to the number of critical results detected by the laboratory information system. #The percentage of unsuccessful notifications was calculated with respect to the number of critical results detected by the laboratory information system. §Turnaround time is presented as median and interquartile range of the time between the apparition of a critical notification request in the laboratory information system and its filling with the univocal identification of the professional receiving the notification. $The classification of turnaround time according to reference | |||||||
Size of critical results regarding analyte and respective department notified by phone during the assessment
| Calcium | 6 (4%) | 38 (7%) | 5 (5%) | 6 (9%) | 55 (6%) | 121 (4%) | 176 (4%) |
| Phosphate | 4 (3%) | 61 (11%) | 13 (14%) | 2 (3%) | 80 (9%) | 48 (1%) | 128 (3%) |
| Glucose | 69 (44%) | 129 (22%) | 24 (25%) | 21 (30%) | 243 (27%) | 511 (16%) | 754 (18%) |
| Magnesium | 3 (2%) | 53 (9%) | 7 (7%) | 3 (4%) | 66 (7%) | 97 (3%) | 163 (4%) |
| Potassium | 44 (28%) | 136 (23%) | 34 (35%) | 17 (24%) | 231 (26%) | 401 (13%) | 632 (15%) |
| Sodium | 21 (14%) | 134 (23%) | 6 (6%) | 22 (31%) | 183 (20%) | 596 (19%) | 779 (19%) |
| Troponin I | - | - | - | - | - | 738 (23%) | 738 (18%) |
| Blood gas analysis | 0 (0%) | 22 (4%) | 6 (6%) | 0 (0%) | 28 (3%) | 573 (18%) | 601 (15%) |
| Therapeutic drug monitoring | 0 (0%) | 4 (0.7%) | 0 (0%) | 0 (0%) | 4 (0.4%) | 93 (3%) | 97 (2%) |
| Other | 9 (6%) | 6 (1%) | 1 (1%) | 0 (0%) | 16 (2%) | 34 (1%) | 50 (1%) |
Questionnaire for attending physicians and nurses on the critical result notification protocol
| H. Universitari Son Espases | Physician | 88 (30) | 0 | 0 | 0 | 9 | 36 (0.41) | 43 (0.49) |
| Nurse | 102 (34) | 0 | 7 (0.07) | 10 (0.10) | 16 | 34 (0.33) | 35 (0.34) | |
| Primary Care center | Physician | 72 (24) | 0 | 0 | 1 (0.01) | 2 (0.03) | 17 (0.24) | 52 (0.72) |
| Nurse | 36 (12) | 0 | 0 | 1 (0.03) | 5 (0.14) | 19 (0.53) | 11 (0.30) | |
| Total | 298 (100) | 0 | 7 (0.02) | 12 (0.04) | 32 (0.11) | 106 (0.36) | 141 (0.47) | |
| The satisfaction degree was asked to be graded between 0 (very bad) to 5 (excellent). | ||||||||
Quantification of clinical actions reflected in the medical records reviewed after critical result notification, depending on patient’s origin
| Notification stated at medical record | 6 | 21 | |
| Initiation/change treatment | 51 | 31 | |
| Admission/ Complementary testing | 43 | - | |
| Referred to ER | - | 17 | |
| Inter-consultation | 6 | 2 | |
| Biochemistry testing repeated | 0 | 4 | |
| 100 | 54 | ||
| ER - emergency room. | |||